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Abstract
Introduction: Several approaches have been taken to reduce pre-antiretroviral therapy (ART) losses between HIV testing and
ART initiation in low- and middle-income countries, but a systematic assessment of the evidence has not yet been undertaken.
The aim of this systematic review is to assess the potential for interventions to improve or facilitate linkage to or retention in
pre-ART care and initiation of ART in low- and middle-income settings.
Methods: An electronic search was conducted on Medline, Embase, Global Health, Web of Science and conference databases to
identify studies describing interventions aimed at improving linkage to or retention in pre-ART care or initiation of ART.
Additional searches were conducted to identify on-going trials on this topic, and experts in the field were contacted. An
assessment of the risk of bias was conducted. Interventions were categorized according to key domains in the existing literature.
Results: A total of 11,129 potentially relevant citations were identified, of which 24 were eligible for inclusion, with the majority
(n21) from sub-Saharan Africa. In addition, 15 on-going trials were identified. The most common interventions described
under key domains included: health system interventions (i.e. integration in the setting of antenatal care); patient convenience
and accessibility (i.e. point-of-care CD4 count (POC) testing with immediate results, home-based ART initiation); behaviour
interventions and peer support (i.e. improved communication, patient referral and education) and incentives (i.e. food support).
Several interventions showed favourable outcomes: integration of care and peer supporters increased enrolment into HIV care,
medical incentives increased pre-ART retention, POC CD4 testing and food incentives increased completion of ART eligibility
screening and ART initiation. Most studies focused on the general adult patient population or pregnant women. The majority of
published studies were observational cohort studies, subject to an unclear risk of bias.
Conclusions: Findings suggest that streamlining services to minimize patient visits, providing adequate medical and peer
support, and providing incentives may decrease attrition, but the quality of the current evidence base is low. Few studies have
investigated combined interventions, or assessed the impact of interventions across the HIV cascade. Results from on-going
trials investigating POC CD4 count testing, patient navigation, rapid ART initiation and mobile phone technology may fill the
quality of evidence gap. Further high-quality studies on key population groups are required, with interventions informed by
previously reported barriers to care.
Keywords: HIV; antiretroviral therapy; pre-ART; ART eligibility; ART initiation; retention in care; linkage to care; attrition;
low- and middle-income countries.
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Introduction
The rapid roll-out of antiretroviral therapy (ART) programmes
over the past decade in low- and middle-income countries
has resulted in an estimated 9.7 million HIV-positive indi-
viduals receiving ART by the end of 2012, compared to just
300,000 in 2000 [1]. HIV testing and counselling, the entry
point to care, has also been brought to scale at an impressive
pace [1]. However, overall programmatic success has not
reached its full potential due in part to the high attrition
occurring in the period between HIV testing and ART
initiation. Mathematical modelling studies have shown that
achieving the maximum population-level prevention benefits
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from the proposed universal test and treat strategies is
dependent on successful programmatic outcomes, including
optimum linkage to care rates [24]. It is estimated that
only 65% of those eligible for treatment as of the end of
2012 were currently receiving ART [1,5,6], and by raising the
ART initiation threshold to CD4B500 cells/mL as per World
Health Organization (WHO) guidelines released in July 2013,
coverage is estimated to be considerably lower [1]. If major
progress towards universal access to ART is to be attained
by 2015 then there is an urgent need for HIV programmes
to strengthen the existing HIV continuum of care pathway
and ensure that increased access to HIV testing is accom-
panied by improved linkage to care.
To date, attempts have been made to quantify the losses
occurring along the HIV cascade and describe the barriers to
care, although data from low- and middle-income countries
outside sub-Saharan Africa are scarce. Three recent systema-
tic reviews have consistently shown major attrition occurring
along each step of the HIV cascade in sub-Saharan Africa for
adults. Less than half (4546%) of individuals not yet eligible
for ART were retained in pre-ART care and only two-thirds
(6568%) of ART-eligible individuals initiated ART [79].
A recent HIV cascade analysis conducted in India found
that approximately 70% of HIV-positive patients linked to
care within three months post-diagnosis, with only 65% of
pre-ART patients retained in early care and 67% of ART-
eligible patients who initiated ART within three months [10].
A systematic review investigating patient and programme
level factors associated with retention in care during the pre-
ART period and linkage to ART care in sub-Saharan Africa
found that the commonly cited barriers included psycho-
social (stigma and fear of disclosure), economic (inability
to afford transport costs, distance to healthcare facility) and
health system (long waiting times, shortage of health care
workers) factors [11]. Moreover, poor linkage to care has
been reported among groups such as pregnant women [12]
and children [13]. Among ART-eligible pregnant women in
low- and middle-income countries, 3888% failed to initiate
ART, though point of attrition assessed by the different
studies differ, with financial constraints and fear of stigma
identified as the main obstacles to ART care [12]. High rates
of pre-ART mortality and loss to follow-up prior to starting
ART among children have also been reported in studies from
sub-Saharan Africa [13]. According to the new ART eligibility
criteria recommended by the WHO guidelines, the number of
HIV-positive individuals deemed eligible for ART will increase
considerably; however, it will decrease the time period from
entry to care and ART eligibility and likely reduce attrition in
the pre-ART period [1,14].
Patients in the period between HIV diagnosis and ART
initiation can be divided into three groups: those that enter
into HIV care post-diagnosis, those that remain in pre-ART
care until ART-eligible, and those that initiate ART once
ART eligibility is established. Rosen et al. describe these
three periods as stage 1, 2 and 3, respectively [12]. Several
interventions to improve ART adherence and retention have
been rigorously evaluated [15], including treatment suppor-
ters [16], nutritional support [1719], mobile-text messages
[20]. However, research on interventions to increase linkage
to and retention in pre-ART care and initiation of ART has only
recently emerged. Interventions that have been tested include
point-of-care (POC) CD4 count testing [2123], referral slips
[24], patient navigators [25], home-based HIV testing and ART
initiation [26,27]. The aim of this review is to assess the effect
of interventions to improve or facilitate linkage to or retention
in pre-ART care and initiation of ART in low- and middle-
income settings.
Methods
Randomized trials, comparative non-randomized observa-
tional studies, and comparative before-and-after studies
were eligible for this review. Cohort studies were only
included if the control (comparator) group was contemporary
(delivered at the same time and in the same country).
Studies were eligible if they included HIV-positive patients
in low- and middle-income countries (as defined by the
World Bank [28,29]) at any point before initiating treat-
ment and described an intervention aimed at improving
linkage or retention in pre-ART care or initiation of ART.
Primary outcomes were defined as proportion of HIV-positive
patients 1) retained in pre-ART care, 2) linked to care and
3) initiated on ART as defined by study author and 4) time
to linkage or initiation of ART. Secondary outcome assessed
were: 1) patient satisfaction with care, as defined by the
study authors 2) cost to the provider and 3) cost to the
patient and family.
The literature was searched for available systematic and
narrative reviews investigating linkage to pre-ART, HIV and
ART care and retention in pre-ART care. Five systematic
reviews were identified [710,30] and the reference lists
were hand searched. Additional searches were conducted
in four electronic databases for primary studies: Medline,
Embase, Global Health and Web of Science from the 1st
of January 2004 (start of ART delivery at scale in low- and
middle-income countries) to the 10th of February 2013.
The detailed compound search strategies are described
in Supplementary Tables 13. Three electronic databases
were searched for on-going trials: Cochrane Central Register
of Controlled Trials (CENTRAL), WHO International Clinical
Trial Registry Platform and ClinicalTrials.gov. Furthermore,
a total of 117 experts (Supplementary Tables 4 and 5) were
contacted to identify additional studies either completed
or on-going; these experts were authors of studies included
in this and previous reviews [710] and these experts were
asked to provide additional names of people who were
subsequently contacted in a second round. Finally, reference
lists of all studies identified by the above methods were
screened for potentially eligible studies. Conference abstract
databases of the following conferences were searched: Con-
ferences on HIV Pathogenesis and Treatment of the Inter-
national AIDS Society (IAS, 20012011), Conferences on
Retroviruses and Opportunistic Infections (CROI, 2006
2013) and the International AIDS Conferences (AIDS, 2001
2012). Additional searches were undertaken to identify
subsequent publications of studies presented at conferences.
These searches were conducted in Ovid Medline using
the first and the last authors’ names combined with ‘‘HIV’’
and the country the study was conducted in. Authors of
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publications with potentially relevant data were contacted in
case clarification was needed.
All references identified by the compound search strategy
were imported into EndNote. After duplicates were removed,
titles and abstracts were examined independently by the
two authors (DG, KK). The full text of potentially relevant
studies was obtained and the inclusion criteria were applied
independently using a standardized eligibility form. Data
extraction was performed by KK using a standardized data
extraction form. Information was extracted regarding study
(citation, start and end dates, location, study design and
details), participants (eligibility criteria, age range, gender,
population size, specific high-risk groups, HIV disease pro-
gression), intervention (detailed description of the inter-
vention and standard of care in the control groups) and
outcomes (proportion of individuals with a positive outcome
and time to accessing HIV or ART care). Drawing on knowl-
edge from previous systematic reviews of risk factors and
barriers to care, interventions were categorized as follows:
health system interventions, patient convenience and acces-
sibility, behaviour interventions and peer support, and incen-
tives. In addition, the stage the intervention was targeted at
in the HIV cascade was also highlighted. The risk of bias was
assessed by the Cochrane Effective Practice and Organisation
of Care (EPOC) Group criteria for randomized-controlled and
non-randomized-controlled trials [31] and the Newcastle-
Ottawa Scale for observational studies [32].
Results
Study characteristics
A total of 11,129 potentially relevant citations were iden-
tified, of which 24 were eligible for inclusion (Figure 1). In
addition, 15 on-going trials investigating interventions to
improve linkage and retention in pre-ART care were identi-
fied. Four publications with potentially relevant data could
not be included as authors were unable to provide relevant
data [18,24,33,34]. Characteristics of the included studies
are summarized in Tables 1 and 2. Twenty studies were
published in peer reviewed journals, one was an unpublished
study and three were conference abstracts. There were
21 studies from sub-Saharan Africa (nine countries), two
studies from India [35,36] and one study from Cambodia
[37]. The following patient subgroups were included: patients
co-infected with tuberculosis (TB) (n1) [37], children
(n1) [35], adolescents (n1) [38], inpatients (n1) [39],
injecting drug users (n1) [36] and pregnant women (n9)
[4048]. No studies were identified that investigated in-
terventions in any other key population group (men who
have sex with men, sex workers, the elderly, prisoners and
N=11129 potentially eligible citations identified through:
Search strategy on electronic databases (n=11 048)
Web of Science (n=3102), Medline, EMBASE, COCHRANE 
(n=7946)
Keyword search on electronic conference abstract databases (n=45)
References obtained from experts (n=36)
Screen 1: N=11062 excluded
Articles: n=10994 (n=1622 duplicates, n=9372 irrelevant 
on the basis of title/abstract )
Conference abstracts: n=35 (n=17 ineligible on basis of
study design, n=16 no control group, n=2 retrieved
article)
References from experts: n=33 (n=26 irrelevant on basis
of study design, n=3 retrieved article, n=4
report/protocol)
N=67 of full text articles assessed for eligibility
(54 published articles + 1 unpublished article from experts + 10 conference
abstracts + 2 conference abstracts from experts)
Screen 2: N=43 excluded 
Abstracts: n=8 (no denominator included)
Published articles: N=35 (n=4 re-analysis not
conducted on time, n=29 ineligible based on study
design, n=2 no control group
24 studies retained for analysis
(20 published articles + 1 unpublished article from experts + 2 conference abstracts + 1 
conference abstract from an expert)
Id
en
tif
ic
at
io
n
Sc
re
en
in
g
E
lig
ib
ili
ty
In
cl
ud
ed
Figure 1. Selection process for the inclusion of studies.
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migrants). There were no studies identified from Central Asia,
the Americas or the Pacific region.
The most common interventions described included CD4
count testing with immediate results (e.g. POC technology)
(n4) [2123,38], service integration, mainly in the setting
of antenatal care (n6) [40,42,4548], and wider health
systems interventions including improved communication,
referral and teaching (n4) [37,41,44,49] and incentives
(n2) [35,36]. No study provided data on patient satisfac-
tion and costs. Most studies assessed interventions for stage
3 (ART initiation) (n14) and stage 2 (completion of ART
eligibility screening) (n9) of the HIV cascade, with only six
studies assessing the impact of interventions for stage 1
(linkage to HIV care).
Impact of interventions
The possible impact of interventions was assessed by
comparing proportions of individuals completing staging,
enrolling in care, accessing follow-up care or initiating ART in
the intervention and control group or by comparing the
median time to a positive outcome in individuals receiving
the standard of care or the intervention. The definitions
of successful outcomes were heterogeneous across studies
(Tables 1 and 2) and thus effects of the similar or differ-
ent interventions were difficult to compare. Studies often
reported multiple outcomes along the different steps of the
pre-ART period.
Health system interventions
Integration
Integration of ART and antenatal care increased enrolment
in HIV care and ART initiation in five out of six observa-
tional studies (Tables 1, 2 and 3) [40,42,4648], with the
largest effect observed in a before/after study from Zambia,
with pregnant women in the intervention group twice as
likely to enrol in HIV care [adjusted odd ratio (aOR)2.06
(1.273.34)] and initiate ART [aOR2.0 (1.372.95)] within
60 days post-diagnosis [47]. An observational study from
South Africa examining the impact of integrated ART services
within an antenatal care setting showed that pregnant
women in the intervention group were less likely to initiate
ART compared to the control group [hazard ratio (HR)0.62
(0.371.04)] [45].
Comprehensive HIV care
Three before/after studies investigating packages of health
systems interventions aimed at improving referrals, commu-
nication and teaching showed an increase in ART initiation by
15% in pregnant women in South Africa [44], by 27% in eight
weeks in TB patients in Cambodia [adjusted HR (aHR) for ART
initiation within eight weeks post-TB diagnosis2.60 (1.87
3.62)] [37] and by 15% in unselected adults in Swaziland [49].
Task shifting
A post hoc analysis of a cluster randomized trial primarily
investigating the effect of task-shifting to nurses on mortality
found no difference in attrition during pre-ARTcare six months
post-enrolment in South Africa [relative risk (RR) 1.02
(0.921.18)] [51].
Provider-initiated testing and counselling
A before/after study in Zambia found that patients who
underwent Provider-initiated testing and counselling (PITC)
had a significantly lower odds of ART initiation [aOR0.90
(0.820.97)] and pre-ART retention [aOR0.84 (0.740.95)]
[53].
Patient convenience and accessibility
Immediate CD4 count testing
POC CD4 count testing at the time of HIV diagnosis increased
the proportion of patients completing an ART eligibility as-
sessment (44% vs. 79%) and reduced time to ART initiation
(48 to 20 days pB0.0001) [21] in a before/after study in
Mozambique. In another study from South Africa, POC CD4
testing doubled ART initiation at healthcare facilities within
60 days post-diagnosis [likelihood ratio2.01 (1.393.17)]
and in a randomized controlled trial in South Africa [relative
likelihood ratio 2.10 (1.393.17)] [21,22]. However, POC
CD4 count technology had less of an impact on retention in
pre-ART care for individuals not yet eligible for ART [likelihood
ratio: 1.02 (0.721.45)] [22] and on linkage to HIV services
among individuals accessing a mobile HIV testing service
[RR1.23 (1.001.57)] [23].
Home-based ART initiation
A cluster randomized trial from Malawi showed that optional
availability of home-based eligibility assessment following HIV
self-testing and ART initiation resulted in a threefold increase
in the risk of population-based ART initiation [risk ratio2.94
(2.104.12)] [26].
Inpatient testing and counselling, home visits
Similarly, a higher proportion of patients randomized to
receive HIV testing as inpatients linked to HIV services (21%)
compared to patients who were referred for outpatient HIV
testing following discharge from hospital (16%) [39]; however,
the result did not reach statistical significance (p0.174).
Behaviour interventions and peer support
Extended counselling and peer support
A randomized controlled trial conducted in Uganda showed
that intensified post-test counselling and monthly visits by
a peer support worker almost doubled linkage to HIV care
five months post-diagnosis [HR1.8, (1.422.1)] [52]. A peer
support intervention among pregnant women in a cluster
randomized trial conducted in the Democratic Republic of
Congo led to a 39% increase in linkage to HIV care [HR1.39
(1.011.91)] [43], but these results have yet to be formally
published.
Peer navigator
Visits by peer navigators also increased the likelihood of
seeking care following a community-based HIV testing cam-
paign in a observational study conducted in Kenya at 10
months for men (aHR1.35 (0.971.87)] and women
[aHR1.20 (1.001.43)] [25]; however, individuals not re-
ceiving peer navigator visits were a highly selected group and
therefore the results should be interpreted with caution.
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Table 1. Description of full-text studies included in the review (listed alphabetically by country)
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
Choun [37] 20082011 Cambodia Phnom Penh, 1
hospital
(outpatient), TB
patients
20082010:
extrapulmonary TB,
pulmonary TB and
CD4 B350 cells/mL
20102011:
All TB patients
Before/after
study
Intervention
Communication
Weekly medical department meeting (TB and HIV
physicians)
Monthly multidisciplinary meeting of key HIV and TB
care staff to discuss logistical, managerial,
operational issues
Daily educational activities for HIV patients attending
the HIV clinic
Preparation of implementation
Required changes in patient flow discussed: key
changes consisted of more rapid pre-ART counselling
and fast-tracking for ART initiation
No concurrent changes in TB case-finding strategies or
TB and HIV care clinic organizational set-up (staffing,
HIV/TB service delivery model)
Fixed starting date of implementation
Monitoring
Within each service, supervisors monitored adherence
to the implementation during their routine (clinical)
work as part of their continuous monitoring of all
guidelines and practices
Operational challenges with implementation were
raised by staff meetings
 Proportion of individuals
starting ART within 4 or 8
weeks of TB diagnosis
 Time from TB diagnosis to
ART initiation
Age and sex were similar in control
and intervention group
CD4 (cells/mL) median (IQR):
Control: 59 (18168)
Intervention: 43 (20163)
No outcome verification
Adjustment for confounding
(CD4 count, extrapulmonary TB,
enrolment in HIV care before TB
diagnosis)
Kundu [35] 20082009 India Kolkata (urban),
1 tertiary
hospital
(outpatients),
children
Not stated Before/after
study
Control (SOC): Caregivers were advised to follow-up in
the paediatric pre-ART clinic at least once in 2 months.
If children failed to visit the clinic 2 months, then
guardians were contacted by phone call
Intervention: Provision of supplementary nutrition as
monthly take home rations The rations were
distributed outside the hospital premises on the
principle of providing one-third calorie and one-half
proteins of recommended daily allowance for the age
of the child
 Proportion of children with
regular pre-ART follow-up
(6 visits per year) over a
12 months period
 Proportion of children
remaining in care (children
with an appointment within
the last 6 months) over a
12-month period
Potential for survival bias
(3 children died, 6 children were
lost to follow-up and 11 children
started ART during the first year
(control))
No adjustment for confounding
Hatcher [25] 2009 Kenya Nyanza (rural)
community-
based testing,
adults
CD4 cell count
B250 cells/mL
Observational
study with
control group
Control: No home follow-up
Intervention: Follow-up home visit by a trained PLHA
navigator
 Proportion of individuals
enrolled at a clinic 10 months
after the positive HIV test
Only individuals who consented to a
home visit were assigned the inter-
vention andonly individualswhowere
located received the intervention
Outcomes were only ascertained
for individuals traced and found
10 months after the testing
No outcome verification,
ascertainment of outcome through
self-report
Adjustment for confounding (age,
education, ART knowledge,
discrimination, disclosure health
status, distance to HIV clinic)
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Table 1 (Continued )
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
Kohler [50] 20052007 Kenya Nairobi (urban),
1 outpatient site
in a secondary
hospital
CD4 cell count
B250 cells/mL or
WHO stage 3 or 4
Before/after
study
Control: 6 monthly health care visits for patients not
yet eligible for ART, follow-up through phone calls
for patients with missed appointments
Intervention: Free co-trimoxazole, scheduled
monthly visits for refill, follow-up through phone
calls for patients with missed appointments
 Proportion of individuals
not yet eligible for ART in
care 12 months after
enrolment
Age, sex and BMI were similar in
the intervention and control group
CD4 (cells/mL) median:
Control: 412
Intervention: 441
Adjustment for confounding (age,
sex, CD4 count)
MacPherson
[26]
2012 Malawi Northwest
Blantyre (urban),
community,
adult residents
(16 years of
age)
CD4 cell count
B350 cells/mL, WHO
stage 3 or 4,
pregnant or
breastfeeding
Cluster
randomized
trial
Control: HIV self-testing kits were available for all
cluster residents through community counsellors. All
individuals who requested self-testing could do so in
the privacy of their home. They were asked to return
the used kit, but were told that they were not
required to disclose the result, but if they wish to do
so they would receive post-test counselling. All self-
testing participants received a self-referral card to
access HIV care (and ART if eligible) at local health
facilities
Intervention: Self-testing and facility-based HIV care
was available for all community members as in the
control clusters. Individuals who disclosed a positive
result to the community counsellor could opt to
receive home-based initiation of HIV care. If
requested a study nurse would undertake a home
visit within 3 days and perform confirmatory testing,
ART eligibility assessment (CD4 count, WHO stage),
undertake TB screening and provide INH and the
first of the two treatment preparedness sessions. At
a second visit individuals who met national eligibility
criteria received 2 weeks of ART before transfer into
the routine clinic system.
 Proportion of individuals
initiated on ART among adult
cluster residents
Age and sex was equally balanced
in intervention and control clusters
No outcome verification
Outcome was assessed blinded to
the intervention
Adjustment for clustering
Weigel [41] 20062009 Malawi Lilongwe (rural),
1 antenatal care
clinic, pregnant
women
CD4 cell count
B250 cells/mL or
WHO stage 3 or 4
Before/after
study
Intervention
July 2006: CD4 testing at 1st ANC visit during
provider initiated testing and counselling,
introduction of referral slip Sept 2006: Vehicle for
transport of women from ANC to ART clinic, Health
passports provided free to pregnant women
Dec 2006:New ART centre opens 200 m walking
distance from ANC clinic; identification of ART clinic
staff member acting as a link person to ANC and
being responsible for ‘PMTCT women’
May 2007: No queuing for pregnant women, no
guardian required to start ART on the same day
Mar 2008: introduction of leaflets and poster
signposts to mark the way from ANC to ART
Dec 2008: introduction and use of an electronic data
system with a unique hospital number
Oct 2009: New ANC and maternity opens opposite
of ART site
 Proportion of pregnant
women who registered with
the ART clinic if they had a
CD4 count
 Proportion of pregnant
women who initiated ART
among the ones who had
registered
Age and CD4 counts similar across
years
Small sample size in the initial year
(2006)
Outcomes were not time delineated
(maximum and minimum follow-up
time unknown)
No adjustment for confounding
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Table 1 (Continued )
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
Jani [21] 20092010 Mozambique Maputo and
Sofala (rural and
per-urban), 4
primary health
care clinic, 1
year
15 years:
CD4 cell count
B250 cells/mL
415 years:
B350 cells/mL
14 years:
B750 cells/mL
Before/after
study
Control: Blood samples for CD4 counts were
collected once a week and sent to a nearby
laboratory, patients were asked to return for a
staging visit after the test results were available
Intervention: POC CD4 count testing was done on
the same day in the phlebotomy room where a
laboratory assistant tested fingerpick samples
Patients with results were referred to consultation
rooms to be staged and to have eligibility assessed
on the same day
 Proportion of individuals who
completed a staging visit
(receipt of CD4 result and
assessment of ARTeligibility)
within 90 days of testing
 Proportion of individuals
initiating ART if found eligible
within 60 days of testing
 Days between CD4 result and
ART initiation for participants
found eligible
 Proportion of individuals
initiating ART within 150 days
of testing
 Days between testing and ART
initiation
Age and sex were similar in control
and intervention group
No outcome verification (outcome
was ascertained through folder
review)
Adjustment for confounding (age,
sex, clinic)
Pfeiffer [48] 20042007 Mozambique Manica and
Sofala districts
(rural and urban)
Not stated Observational
study with
control group
Control: vertical, donor-initiated, day hospital
(HIV treatment hospitals in large population
centres alongside existing hospital compounds)
Intervention: decentralization and integration of HIV-
related programmes into primary health care
services:
1) co-location of different services within the same
facility
2) training of personnel to provide multiple services,
3) provision of tools, processes and training to
better link services
4) strengthening of linkages, referral and follow-up
between facility levels
5) harmonization of logistic systems
 Proportion of eligible
individuals initiatingARTwithin
90 days
 Proportion of HIV-positive
pregnantwomen registered for
HIV care within 30 days of
testing
No data on denominators
presented
No baseline data
No outcome verification (routine
data collection)
No adjustment
Tsague [40] 2008 Rwanda National,
pregnant
women
No stated Observational
study with
control group
Control (‘‘stand-alone’’): only PMTCT services were
available at the ANC site
Intervention (‘‘full package’’): PMTCT and ART
services were both available on site
 Proportion of HIV-positive
pregnant women undergoing
a CD4 cell count assessment
during pregnancy
 Proportion of HIV-positive
pregnant women enrolling
into HIV care and treatment
during pregnancy
 Proportion of eligible HIV-
positive pregnant women
initiating ART during
pregnancy
No outcome verification
No baseline data (routine data
collection)
No adjustment, no controlling for
clustering
Larson [23] 2010 South Africa Johannesburg, 2
mobile clinics,
adults
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Observational
study with
control group
Control (SOC): patients with a positive HIV test result
received post-test counselling and referral to an HIV
care and treatment site
Intervention: SOC POC CD4 count testing
 Proportion of individuals
enrolling in HIV care within 8
weeks of HIV testing
Mean age was similar in control and
intervention group. There were more
women (62%) in the intervention
group compared to the control group
(55%)
Outcome was only ascertained in 63%
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Table 1 (Continued )
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
No outcome verification, outcome
ascertainment through self-report
Adjustment for age, sex, previous
HIV testing experience
Faal [22] 2009 South Africa Johannesburg
(urban),
1 primary health
care clinic,
adults
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Individual
randomized
controlled trial
Control A: blood for CD4 count was drawn at the
time of testing, patients were required to return to
receive the result
Control B: blood for CD4 count was drawn at the
time of testing, patients were required to return to
receive the result, but they received a leaflet with
information
Intervention: blood for CD4 count was drawn at the
time of testing and the patient received the result
on the same day
 Proportion of individuals
reporting for further care
within 1 month of HIV testing
if not yet eligible (CD4 count
215 cells/mL)
 Proportion of individuals
initiating ART within 3
months of HIV testing if
eligible (CD4 count B215
cells/mL)
Baseline variables were distributed
equally across the groups
No outcome verification
Fairall [51] 20082010 South Africa Free State
(urban and
rural), 31
primary health
care clinics,
adults (16
years of age)
Non-pregnant
women and men:
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Pregnant women:
CD4 cell count
B350 cells/mL
Cluster
randomized
control trial
Control: Patients diagnosed with HIV were referred
to designated nurse-led clinics to establish whether
they were eligible for ART. Patients not yet eligible
for ART received routine care, such as regular CD4
testing, until they became eligible. Patients eligible
for ART were referred to ART treatment sites in
hospital outpatient departments for initiation of
treatment and review of ART prescriptions every
36 months, done by a doctor
Intervention: Prescribing nurses received at least
four educational outreach training sessions about
ART prescribing and side-effects with a special
edition of the PALSA PLUS guidelines, which
included algorithms to start and to monitor patients
on ART, and to identify those needing referral to a
doctor. Patients had to meet certain criteria for
nurse initiation and re-prescription of ART. Patients
who did not meet these criteria were referred to
doctors who, unlike nurses, were authorized to
initiate tailored regimens, to change prescriptions,
and to prescribe second-line drugs
 Proportion of individuals in
HIV care (either pre-ART care
or ART care) 6 months of
enrolment visit among
individuals with CD4 count
B350 cell/mL
Age and sex was similar in
intervention and control clusters
CD4 (cells/mL) median (IQR):
Control: 158 (78232)
Intervention: 163 (84241)
No outcome verification
Ad-hoc sub-analysis (not the
primary endpoint of the trial)
Adjustment for clustering
Youngleson
[44]
20062009 South Africa Western Cape
(urban and
rural), 17
antenatal care
clinics, pregnant
women
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Before/after
study
Control: Stand-alone ANC clinic
Intervention: Resource addition and process
improvement
Six learning workshops between 20062009 for facility
staff and managers
Additional HAART clinic at primary care site with large
antenatal clinic and high HIV prevalence
Improved communication between ANC and ARTclinic,
antenatal clients were walked over to ART room
‘Mother’s Day’: dedicated ART clinic day each week for
pregnant women needing ART
Mother2mothers program: support and education to
women in PMTCT program
 Proportion of pregnant
women who were receiving
ART at time of delivery
among all women testing HIV
positive
No information on age and CD4
count
No outcome verification
No adjustment for confounding
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Table 1 (Continued )
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
Stinson [45] 2005 South Africa Cape Town, 3
antenatal care
clinics, pregnant
women
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Observational
study with
control group
Control: eligible women were referred to an ART
clinic within 5 km
Proximal service: eligible women were referred to an
ART clinic, which was on the same premises, but not
in the same building
Integrated service: outreach doctors came to the
ANC clinic twice a week
 Proportion of ART eligible
pregnant women initiated on
ART during pregnancy
Age was similar in all three groups
CD4 (cells/mL) median (IQR):
Control: 139 (106172)
Proximal: 135 (94167)
Integration: 143 (97171)
Only three clinics were included
No outcome verification
Adjustment for age and gestational
age
Van der
Merwe
[46]
20042005 South Africa Gauteng
(urban), 1
hospital,
outpatient,
antenatal care,
pregnant
women
CD4 cell count
B200 cells/mL or
WHO stage 4 disease
Before/after
study
Control: Women were referred to an off-site ART
clinic
Intervention: ART clinician came to the ANC clinic
once a week
CD4 count were performed at the first ANC visit
Women received the CD4 count at the second ANC
visit and had baseline bloods if CD count B250
cells/mL
For women eligible for ART, adherence counselling
and treatment preparation was scheduled for the
2nd visit
 Time from eligibility
assessment to initiation of
ART for pregnant women
eligible for ART
Age was similar in all three
groups
CD4 (cells/mL) median (IQR):
Control: 146 (117178)
Intervention: 143 (92186)
No outcome verification
No adjustment for confounding
Burtle [49] 20092010 Swaziland Lumbombo
(rural), 1
secondary
hospital, all
patients
(excluding
pregnant
women and
patients with
TB)
CD4 cell count
B200 cell/mL or
WHO stage 4
Before/after
study
Control: HIV care prior to commencing ART was
episodic
Intervention: 1) comprehensive care using a patient
care pathway (with three records inpatient pre-ART
file, patient hand-held file, pre-ART registration
book), 2) active follow-up by cell phone and
adherence officers 3) task shifting to nurses and lay
counsellors
 Proportion of individuals
with documents assessment
of eligibility
 Proportion of ART eligible
individuals initiated on ART
 Days between eligibility
assessment and ART
initiation
Age and sex were similar in baseline
group, during implementation of
the intervention, one year after
implementing the intervention
CD4 (cells/mL) median (range):
Baseline: 281 (22003)
Implementation: 292 (22777)
Post implementation: 241
(41815)
No outcome verification
Outcomes were not time
delineated, the minimum and
maximum time of follow-up was 3
and 15 months
Muhamadi
[52]
20092010 Uganda Iganga (rural), 1
outpatient site
in a secondary
hospital, 2
primary health
care centres,
Not stated Individual
randomized
controlled trial
Control: Post-test counselling by staff not trained in
basic counselling skills and included declaration of
the results, provision of co-trimoxazole prophylaxis
and advice to the client to go for pre-ARV care every
three months
Intervention: Specialized counselling by health care
workers who had been trained on basic counselling
skills for 3 days. The counselling included declaration
of the results, provision of co-trimoxazole
prophylaxis and advice to the client to go for pre-
ARV every three months plus encouragement of
disclosure of the HIV status, HIV prevention and
emphasized the importance of going to pre-ART
care. In addition the participants were attached to
 Proportion of individuals
enrolled in pre-ART care 5
months after testing
Age and sex were similar in control
and intervention group
CD4 count was not measured
No outcome verification, outcome
ascertainment through self-report
Adjustment for several variables
(recruitment centre, age, sex,
marital status)
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Table 1 (Continued )
Author Year of study Country Setting ART eligibility criteria Study design Intervention and control Outcome measures Comments
an HIV/AIDS community support agent close to
their area of resident who visited them monthly
at their homes for a two hour counselling session
and reminded them to go for quarterly pre-ARV
care
Wanyenze
[39]
20042005 Uganda Kampala
(urban), 1
tertiary hospital,
adult inpatients
CD4 cell count
B200 cells/mL or
WHO stage 4 (but
free ARV not widely
available)
Individual
randomized
controlled trial
Control: Testing as an outpatient (a referral card and
an appointment to return to the hospital 1 week
after discharge was provided, transport was
reimbursed)
Intervention: Testing as an inpatient (testing was
conducted within the medical ward and the patient
underwent phlebotomy and serological testing, the
results were disclosed the following day)
 Proportion of individuals
attending an HIV clinic within
6 months of testing for those
testing positive
Age and sex were similar in control
and intervention group
CD4 count was not measured
No outcome verification, outcome
ascertainment through self-report
The analysis used the number of
participants testing positive as
denominator, not the number of
participants enrolled in each group
Topp [53] 20082011 Zambia Lusaka (urban),
7 primary health
care clinics with
voluntary testing
and counselling,
provider
initiated testing
and counselling
was introduced
in a step wise
approach
CD4 cell count
B200 cells/mL or
WHO stage 3 or 4
Observational
study with
control group
Control (VCT): Staffed by nurses whose primary
responsibility lay elsewhere, but they provided VCT
in a spare room in their free time. The service was
available on an ad hoc basis. The majority of clients
were self-initiated and counselling was conducted
according to psychosocial principles without
reference to clients’ clinical condition. If a client
tested positive they received a referral slip and
required to self-present to the HIV care department
Intervention (PITC): PITC was offered routinely on an
opt-out basis to all clients attending the OPD. PITC
was located within the OPD and was part of the
patient flow (no separate queuing). PITC was offered
by lay personnel and thus only available Monday-
Friday 5 hours per day
 Proportion of ART eligible
individuals initiated on ART
 Proportion retained in care at
6 months (including pre-ART
and ART care)
Proportion retained in care at 6
months (including pre-ART and ART
care)
CD4 (cells/mL) median (IQR):
Control: 224 (110387)
Intervention: 264 (137427)
One of the outcomes (proportion
initiating ART) was not time
delineated, the minimum and
maximum time of follow-up was 1
and 36 months
No outcome verification
Adjustment for confounding
and clustering (age, sex, CD4
count, TB, BMI, education, HIV
status)
Killam [47] 20072008 Zambia Lusaka, 8
primary health
care clinics,
antenatal care,
pregnant
women
CD4 cell count
B350 cells/mL or
WHO stage 3 or 4
Before/after
study
Control: ART clinic located on the same premises as
the ANC clinic, but physically separate and
separately staffed
Intervention: ART provision in the ANC clinic, ART
services were provided 12 days per week
 Proportion of ART eligible
pregnant women enrolling in
ART care within 60 days of
testing and before estimated
date of delivery
 Proportion of ART eligible
pregnant women initiated on
ART within 60 days of testing
and before estimated date of
delivery
Age was similar in control and
intervention group
CD4 (cells/mL) mean (SD):
Control: 161 (61)
Intervention: 166 (58)
Adjustment for clinic clustering
Patten [38] 20102011 South Africa Cape Town,
primary
healthcare clinic,
youth
Before August 2011:
CD4 cell count
B250 cells/mL or
WHO stage 3 or 4
After August 2011:
CD4 cell count
B350 cells/mL or
WHO stage 3 or 4
Before/after
study
Control: blood for laboratory CD4 count was drawn
at on the day of an HIV-positive diagnosis and,
patients were required to return to receive the
result
Intervention: POC CD4 count testing and notification
of results were done on the same day of an HIV 
positive diagnosis
 Assessment of ART eligibility
 Proportion of ART eligible
HIV-positive youth initiated
on ART
 Time to ART initiation
Age was similar in control and
intervention group. There were
significant difference in sex
between the ‘‘control’’ and the
‘‘intervention’’ group
CD4 (cells/mL) median (IQR):
Control: 355 (242491)
Intervention: 414 (316548)
G
o
vin
d
a
sa
m
y
D
e
t
a
l.
Jo
u
rn
a
l
o
f
th
e
In
te
rn
a
tio
n
a
l
A
ID
S
So
cie
ty
2
0
1
4
,
1
7
:1
9
0
3
2
h
ttp
://w
w
w
.jia
so
cie
ty.o
rg
/in
d
e
x.p
h
p
/jia
s/a
rticle
/vie
w
/1
9
0
3
2
|
h
ttp
://d
x.d
o
i.o
rg
/1
0
.7
4
4
8
/IA
S.1
7
.1
.1
9
0
3
2
1
0
Incentives
Food
Two studies from India investigated the effect of food
incentives on retention in pre-ART care and ART initiation.
In the first study, the introduction of monthly food supple-
ments increased the proportion of children regularly visiting
the clinic over a one year period from 81 to 93% [HR2.89,
(1.097.63)]; however, this study was a before/after design
and these findings are subject to survival bias as more children
were reported dead and lost to follow-up in the control arm
(9%) than the intervention arm (4%) [35]. The second study,
a randomized controlled trial in injecting drug users,
showed that the median time to ART initiation was seven
days in individuals receiving food vouchers compared to
58 days in individuals not receiving food vouchers [36].
Medical
A third study, from Kenya, found that scheduled and regular
visits during the pre-ART period for the purpose of co-
trimoxazole refill increased pre-ART retention at 12 months
post-enrolment by 20% [50].
On-going trials
Fifteen on-going or planned trials were identified (Table 4).
The majority (n13) of trials are underway in sub-Saharan
Africa, six of them in Kenya, and seek to assess interventions
for injecting drug users (n3) and pregnant women (n5).
Proposed interventions include POC CD4 count testing,
rapid (same day) ART initiation, integration, peer educators,
intensive counselling, assisted partner notification, home-
based male partner testing and short text messages. The
majority of trials will be completed by January 2015.
Quality of studies
Most studies included in this review were observational
studies; either times series (before/after studies) (n10) or
contemporaneous comparative studies (n7). There were
three cluster randomized controlled trials [26,43,51] and four
individual randomized trials [36,39,52,22]. Age, sex and
CD4 count distributions in control and intervention groups,
outcome verification and ascertainment, time delineation
of the outcome and controlling for confounding and cluster-
ing are described in Table 5. Among the 20 peer-reviewed
studies assessed for quality of the evidence, the majority
(n8) were rated as having an unclear risk of bias; four
studies were classified as being at high risk of bias.
Of the four peer-reviewed randomized trials assessed
for study quality, the majority were categorized as having
low risk of bias (n3) with key quality concerns related to
the random sequence generation, allocation concealment
and reporting. Of the 16 remaining observational studies,
most had an unclear risk of bias (n7) and four studies were
rated as having a high risk of bias, with the main quality
issues related to uneven distribution of baseline character-
istics, no adjustment for confounders, and lack of data
related to patient follow-up.
Discussion
This review identified 24 published studies and 15 on-going
trials assessing interventions to improve or facilitate linkageTa
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Table 2. Description of conference abstracts included in the review
Conference
Year of
Conference Author
Year of
study Country Setting Group
Study
Design Intervention and Stage
Outcome
Measures Result
19th International
AIDS conference
2012 Edmonds
[43]
20102011 Democratic
Republic of
Congo
Kinshasa,
HIV care and
treatment
services
Pregnant
women
Cluster
randomized
trial
Health system:
HIV positive volunteers
trained in basic
motivational
educational techniques
who encouraged (and
accompanied) women
to enrol in HIV
treatment and care.
Stage 1
Uptake of
HIV
treatment
and care
Cluster adjusted
hazard ratio was
1.39 (95% CI 1.01
1.91) comparing
intervention vs.
control clinics
20th Conference on
Retroviruses and
Opportunistic
Infections
2013 Myer [42] 2011 South Africa Cape Town,
ANC and
ART services
Pregnant
women
Sequential
before/after
design
Behaviour and peer
support:
Enhanced linkage
PMTCT peer counsellors
to accompany ART
eligible women from
ANC to ART services
Health system:
Integrationnurse-
midwives provided ART
within ANC
Stage 3
Initiation of
ART before
delivery
Pre-intervention:
21% (58/271)
Enhanced linkage:
49% (77/157)
Integration: 85%
(183/214)
19th Conference on
Retroviruses and
Opportunistic
Infections
2012 Solomon
[36]
20092011 India Chennai Injecting
drug users
Individual
randomized
trial
Incentives
Vouchers that could be
redeemed for groceries
or household items for
attending visits at
government ART
centres; initiating ART;
and viral suppression at
6- and 12-months.
Stage 3
Time to ART
initiation
and number
of timely
visits to the
government
centre
Time to initiation: 7
days (intervention)
58 days (control)
The median number
of timely visits to
the government
centre was greater
8 (intervention) 3.5
(control)
ARTantiretroviral therapy; CIconfidence interval; PMTCTprevention of mother to child transmission; ANCantenatal care.
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Table 3. Results (as reported by the authors) of full-text studies included in the review
Authors Group Intervention Outcome: control group
Outcome: intervention
group
Unadjusted relative/risk/
hazard/odds ratio
Adjusted relative/risk/
hazard/odds ratio
Time to outcome:
control group,
median (IQR)
Time to outcome:
intervention group,
median (IQR)
STAGE 1
Tsague [40] Pregnant women Health system: Integration CD4 count assessment:
111/195 (57%)
Enrolling in care: 69/195
(35%)
CD4 count assessment:
547/743 (74%)
Enrolling in care: 495/
743 (67%)
Relative risk for CD4 count
assessment: 1.3 (1.11.4)
Relative risk for enrolling
in care:
1.9 (1.52.3)
Pfeiffer [48] Unselected and
pregnant women
Health system: Integration,
decentralization
Relative risk for registering
with HIV care pregnant
women:
2.53 (1.883.4)
Larson [23] Unselected, tested
at a mobile service
Patient convenience and
accessibility: Immediate CD4 count
testing
Linkage to HIV care: 57/
122 (47%)
Linkage to HIV care:
117/197 (59%)
Relative risk for linkage
to HIV care:
1.23 (1.001.57)
Absolute risk for linkage
to HIV care: 12.7%
(1.523.9)
Wanyenze
[39]
Inpatients Patient convenience and
accessibility: Inpatient testing and
counselling, home visits
Linkage to HIV care: 39/
249 (16%)
Linkage to HIV care:
52/250 (21%)
Hatcher [25] Adults community
testing campaign
Behaviour and peer support:
Peer navigator
HR for enrolment at 10 m
for men: 1.48 (1.082.04)
for women: 1.34 (1.01
1.63)
HR for enrolment at 10 m:
for men 25 Y: 1.35
(0.971.87)
for women: 1.20
(1.001.43)
Killam [47] Pregnant women Health system: Integration HIV care enrolment:
181/716 (25%)
HIV care enrolment:
376/846 (44%)
OR for HIV care enrolment
2.36 (1.902.94)
OR for HIV care
enrolment 2.06
(1.273.34)
STAGE 2
Burtle [49] Unselected Health system: Comprehensive HIV
care
Assessment for ART
eligibility: 118/200 (59%)
Assessment for ART
eligibility: 152/200
(76%)
Fairall [51] Unselected Health system: Task shifting Enrolment into pre-ART
and ART care: 1229/2022
(85%)
Enrolment into
pre-ART and ART
care:
1229/2022 (85%)
1756/2686 (86%)
Enrolment into pre-ART
and ART care:
1.02 (0.921.18)
Jani [21] Unselected Patient convenience and
accessibility: Immediate CD4 count
testing
Enrolment into pre-ART
and ART care:
1.02 (0.921.18)
Completion of staging:
345/437 (79%)
OR for not completing
staging:
0.21 (0.150.27)
OR for not completing
staging:
0.20 (0.150.27)
Time to
completion of
staging:
32 days (1964)
Time between
staging and
initiation:
5 days (019)
Time to completion
of staging:
3 days (013)
Time between staging
and initiation: 6 days
(022)
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Table 3 (Continued )
Authors Group Intervention Outcome: control group
Outcome: intervention
group
Unadjusted relative/risk/
hazard/odds ratio
Adjusted relative/risk/
hazard/odds ratio
Time to outcome:
control group,
median (IQR)
Time to outcome:
intervention group,
median (IQR)
Faal [22] Unselected Patient convenience and
accessibility: Immediate CD4 count
testing
Retention in pre-ART
care: 52/139 (37%)
Retention in pre-ART
care: 31/81 (38%)
Likelihood for retention in
pre-ART care:
1.02 (0.721.45)
Patten [38] Youth Patient convenience and
accessibility: Immediate CD4 count
testing
Assessment for ART
eligibility: 183/272 (67%)
Assessment for ART
eligibility: 275/304
(90%)
Relative risk for
assessment of ART
eligibility 2.4 ( 1.83.4)
Time to eligibility
assessment:
36 days
Time to eligibility
assessment:
28 days
Muhamadi
[52]
Unselected Behaviour and peer support:
Extended counselling and peer
support
Enrolment into pre-ART
care: 77/200 (39%)
Enrolment into pre-
ART care: 135/200
(68%)
RR for enrolment in
pre-ART care at 5 m:
1.8 (1.42.1)
Kundu [35] Children Incentives:
Food supplement
Regular follow-up 81/
100 (81%)
Retention in care: 92/
100 (92%)
Dead and LTFU in pre-
ART care: 9/100 (9%)
Regular follow-up in
pre-ART care: 74/80
(93%)
Retention in pre-ART
care: 78/80 (98%)
Dead and LTFU in
pre-ART care: 3/80
(4%)
HR for irregular follow-up
in pre-ART care: 2.89
(1.097.63)
Kohler [50] Unselected Incentives: Co-trimoxazole with 1
monthly refill
Retention in pre-ART
care: 384/610 (63%)
Retention in pre-ART
care: 344/414 (83%)
HR for being LTFU in pre-
ART care at 12 m:
2.64 (1.953.57)
STAGE 3
Choun [37] Individuals
diagnosed with TB
Health system: Integration ART initiation: 4 weeks:
60/262 (23%)
ART initiation: 8 weeks:
170/262 (65%)
ART initiation: 4
weeks: 118/190 (62%)
ART initiation: 8
weeks: 175/190 (92%)
HR for ART initiation at 8
weeks:
2.45 (1.793.65)
HR for ART initiation at 8
weeks:
2.60 (1.873.62)
Time to ART
initiation:
6.3 weeks
(4.110.0)
Time to ART initiation:
3.1 weeks
(2.45.1)
Tsague [40] Pregnant women Health system: Integration ART initiation: 22/26
(85%)
ART initiation: 105/134
(78%)
Relative risk for ART
initiation:
0.9 (0.71.1)
Weigel [41] Pregnant women Health system: Integration Registration with ART clinic:
2006: 14/53 (26%)
2007: 119/279 (43%)
2008: 101/147 (69%)
2009: 110/133 (83%)
ART initiation:
2006: 9/14 (64%)
2007: 94/119 (79%)
2008: 84/101 (83%)
2009: 99/110 (90%)
Young-leson
[44]
Pregnant women Health system: Integration ART initiation: 124/1243
(10%)
ART initiation: 122/486
(25%)
Stinson [45] Pregnant women Health system: Integration ART initiation: 61/130
(47%)
ART initiation: 124/227
(45%)
HR for ART initiation:
0.62 (0.371.04)
Van der
Merwe
[46]
Pregnant women Health system: Integration Time to ART
initiation:
56 days (30103)
Time to ART initiation:
29 days (1245)
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Table 3 (Continued )
Authors Group Intervention Outcome: control group
Outcome: intervention
group
Unadjusted relative/risk/
hazard/odds ratio
Adjusted relative/risk/
hazard/odds ratio
Time to outcome:
control group,
median (IQR)
Time to outcome:
intervention group,
median (IQR)
Pfeiffer [48] Unselected and
pregnant women
Health system: Integration,
decentralization
Relative risk for initiation
ART unselected: 1.58
(1.172.14)
Fairall [51] Unselected Health system:
Task shifting
Enrolment into pre-ART
and ART care: 1229/2022
(85%)
Enrolment into pre-
ART and ART care:
1229/2022 (85%)
1756/2686 (86%)
Relative risk for
enrolment into pre-ART
and ART care:
1.02 (0.921.18)
Burtle [49] Unselected Health system: Comprehensive HIV
care
ART initiation: 36/68
(53%)
ART initiation: 96/118
(81%)
Topp [53] Unselected Health system: Provider initiated
testing and counselling
ART initiation: 4523/
6520 (69%)
Retention in care: 3765/
6079 (62%)
ART initiation: 1187/
1655 (72%)
Retention in care:
1105/1929 (57%)
OR for ART initiation 1.12
(0.991.26)
OR for retention in care
0.82 (0.740.91)
OR for ART initiation 0.90
(0.820.97)
OR for retention in care
0.84 (0.740.95)
Jani [21] Unselected Patient convenience and
accessibility: Immediate CD4 count
testing
ART initiation for eligible
patients: 36/93 (39%)
ART Initiation for all
patients: 57/492 (12%)
ART initiation for
eligible patients: 50/
144 (35%)
ART Initiation for all
patients: 94/437 (22%)
OR for ART initiation in
eligible patients:
0.84 (0.491.45)
OR for ART initiation in all
patients:
2.05 (1.422.96)
OR for ART initiation for
eligible patients 2.84
(0.7610.56)
Time between
staging and
initiation:
5 days (019)
Time between
testing and
initiation:
48 days (3480)
Time between staging
and initiation: 6 days
(022)
Time between testing
and initiation: 20 days
(1031)
Faal [22] Unselected Patient convenience and
accessibility: Immediate CD4 count
testing
Retention in pre-ART/
ART care: 74/220 (34%)
ART initiation: 22/71
(31%)
Retention in pre-ART/
ART care: 59/124 (48%)
ART initiation: 28/43
(65%)
Likelihood for retention in
pre-ART/ART care: 1.41
(1.081.84)
Likelihood for ART
initiation: 2.1 (1.393.17)
Patten [38] Youth Patient convenience and
accessibility: Immediate CD4 count
testing
ART initiation: 22/48
(44%)
ART initiation: 49/99
(50%)
Mac-Pherson
[26]
Community Patient convenience and
accessibility: Home-based ART
initiation
ART initiation: 59/8466
(0.7%)
ART initiation: 180/
8194 (2.2%)
Risk ratio for ART
initiation: 2.94 (2.104.12)
IQRinterquartile range; TBtuberculosis; HRhazard ratio; ARTantiretroviral therapy; LTFUlost to follow-up; ORodds ratio.
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Table 4. Description of on-going trials
Title Status Country Subgroup Intervention Intervention allocation Outcomes Identifier
Linking Infectious and
Narcology Care in Russia
(LINC) [54]
Study start date: June 2012
Study completion date:
April 2016
Russia Injecting drug
users, adults
(18), HIV
infected
HIV case management delivered by a
peer and point of care CD4 count
testing
Individual randomized Proportion of individuals initiating HIV care within
6 months of enrolment
Proportion of individuals retained in HIV care
12 months after enrolment
ClinicalTrials.gov:
NCT01612455
An intervention to improve
antenatal access to CD4
testing an HAART
Botswana [55]
Study start date: July 2011
Study completion date:
October 2012
Botswana Pregnant
women, HIV
infected
Improved access to CD4 phlebotomy,
rapid CD4 result return via SMS
messaging sub-Saharan Africa, active
follow-up of treatment eligible
women, participatory educational
sessions for clinic staff, loan program
for HIV and CD4 testing supplies
Step-wedge, cluster-
randomized
Proportion of eligible pregnant women with CD4
enumeration prior to 26 weeks gestation/prior to
delivery
Proportion of eligible women with HAART
initiation prior to 30 weeks gestation/prior to
delivery
ClinicalTrials.gov:
NCT01836003
Home-based partner
education and testing
(HOPE) Study [56]
Study start date: May 2013
Study completion date:
June 2014
Kenya Pregnant
women and
their partners
Home-based partner education and
HIV testing as part of routine
pregnancy services
Individual randomized Proportion of men linkage to HIV care 6 months
post-partum (self-report)
Proportion of men initiating ART 6 months
post-partum (self-report)
Proportion of women initiating ART 6 and
14 weeks post enrolment and 6 months
postpartum (self-report)
ClinicalTrials.gov:
NCT01784783
WelTel Retain: Promoting
Engagement in Pre-ART
HIV Care Through SMS
[57]
Study start date: January
2013
Study completion date:
March 2015
Kenya Adults (18),
HIV infected
Weekly text-messages sub-Saharan
Africa
Individual randomized Proportion of individuals retained in care at
12 months
Proportion of individuals completing 1st eligibility
assessment within 3 months
Proportion of individuals who complete
3 counselling sessions within 2 months
ClinicalTrials.gov:
NCT01630304
Testing and linkage to care
in injecting drug users in
Kenya [58]
Study start date: March
2012
Study completion date:
April 2015
Kenya Injecting drug
users, adults
(18)
POC CD4 count and peer care
management
Individual randomized Proportion of individuals linking to care (data
collection done in 5 waves separated by 6 months)
Time to ART
ClinicalTrials.gov:
NCT01557998
Assisted partner
notification to augment
HIV treatment and
prevention in Kenya
(APS) [59]
Study start date: June 2012
Study completion date:
May 2015
Kenya Sexual partners
of HIV-positive
individuals
Assisted-partner notification Individual randomized Rate of linkage to HIV care of partners within 6
weeks of index case enrolment
ClinicalTrials.gov:
NCT01616420
Mobile phone technology for
prevention of mother-to-
child transmission of HIV:
acceptability, effectiveness
and cost [60]
Study start date: May 2011
Study completion date:
April 2014
Kenya Pregnant
women, HIV
infected
Mobile phone technology Cluster randomized Proportion of women who successfully complete
key PMTCT transition points from antenatal care to
6 weeks postpartum
Proportion of women on ART during labour,
delivery and postpartum
ClinicalTrials.gov:
NCT01645865
Integration of HIV care and
treatment into antenatal
care in Migori district,
Kenya [61]
Study start date: June 2009
Study completion date:
March 2012
Kenya Pregnant
women, HIV
infected (18)
Integrated ANC (health care providers
within the ANC department will be
trained to provide HIV/PMTCT care)
Cluster randomized Proportion of women enrolled and retained in HIV
care and treatment at 6 months and 1 year
ClinicalTrials.gov:
NCT00931216
Optimizing integrated
PMTCT services in rural
North-Central Nigeria
[62]
Study start date: March
2013
Study completion date:
September 2014
Nigeria Pregnant
women, HIV
infected
Integrated PMTCT package: task-
shifting to lower cadre, POC CD4
count testing, prominent role for male
partners in collaborations with
community health workers
Cluster randomized Proportion of ART eligible pregnant women who
initiated ART for the purposes of PMTCT
ClinicalTrials.gov:
NCT01805752
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Table 4 (Continued )
Title Status Country Subgroup Intervention Intervention allocation Outcomes Identifier
Rapid Initiation of
Antiretroviral Therapy to
Promote Early HIV/AIDS
Treatment in South
Africa (RapIT Study) [63]
Study start date: October
2012
Study completion date:
May 2015
South Africa Non pregnant,
adults (18),
HIV infected
ART initiation on the day of HIV
testing
Individual randomized Proportion of individuals alive, in care and virally
suppressed at 6 months
Average time to ART initiation
ClinicalTrials.gov:NCT0171039
Linkage and Retention:
A Randomised Trial to
Optimize HIV/TB Care in
South Africa (Sizanani)
[64]
Study start date: August
2010
Study completion date:
January 2015
South Africa Adults (18),
HIV infected
Patient navigator and short message
service (SMS), sub-Saharan Africa,
contacts throughout the follow-up
period
Individual randomized Proportion of ART eligible individuals linked and
retained in ART care 9 months after enrolment
ClinicalTrials.gov:
NCT01188941
The "START" (a Streamlined
ART Initiation Strategy)
Study (START-ART) [65]
Study start date: April 2013
Study completion date:
May 2016
Uganda Adults (18),
HIV infected
POC CD4 testing, targeted knowledge
transfer, feedback and reporting to
clinic and providers
Randomized roll-out
to clinics (step-wedge
design)
Cumulative incidence of ART initiation in newly
treatment eligible HIV-positive patients
ClinicalTrials.gov:
NCT01810289
The PeerCARE Study (Peer
Community-based
Assistant in Retention)
[66]
Study start date: June 2011
Study completion date:
June 2014
Uganda Adults (18),
HIV infected
Peer health worker conducting home
visit
Individual randomized Time to ART initiation within 1 year ClinicalTrials.gov:
NCT01366690
HIV counselling and testing
and linkage to care in
Uganda[67]
Study start date: May 2008
Study completion date:
August 2012
Uganda Adult (18)
inpatients
More detailed counselling and
enhanced linkage to care
Individual
randomized(factorial
design)
Proportion of individuals receiving of OI
prophylaxis and adhering to ART
Mortality
ClinicalTrials.gov:
NCT00648232
Enhanced access to HIV
care for drug users in
San Juan, Puerto Rico
[68]
Study start date: August
2013
Study completion date:
April 2017
Puerto Rico Injecting drug
users (18)
1) neighbourhood-level HIV testing
campaign
2) treatment re-engagement
campaign using patient navigators for
out of care HIV positive injecting drug
users.
3) a patient navigator linkage to care
and substance abuse treatment team
4) mobile HIV care clinic to facilitate
linkage and retention
Randomized roll-out
design (similar to the
stepped-wedge
design) in 5
neighbourhoods
Proportion of individuals attending HIV care visit at
6 months intervals
Proportion of individuals initiating ART at 6 months
intervals
ClinicalTrials.gov:
NCT017927252
HAARThighly active antiretroviral therapy; SMSshort message service; ARTantiretroviral therapy; POCpoint-of-care.
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Table 5. Quality assessment of published peer reviewed studies
Author Study design Selection Comparability Outcome Randomized controlled trials Summary
Faal [22] Individual randomized controlled trial Radom sequence generation  unclear risk of bias
Allocation concealment  low risk of bias
Blinding of participants  not feasible
Blinding of outcome assessment  unclear risk of bias
Incomplete outcome data  low risk of bias
Selective reporting  low risk of bias
Other bias  low risk of bias
Low risk
Fairall [51] Cluster randomized control trial Recruitment  low risk of bias
Allocation concealment  low risk of bias
Statistics  low risk of bias
Number of clusters  low risk of bias
Outcome  unclear risk of bias (ad-hoc analysis)
Low risk
Muhamadi [52] Individual randomized controlled trial Radom sequence generation  unclear risk of bias
Allocation concealment  unclear risk of bias
Blinding of participants  not feasible
Blinding of outcome assessment  unclear risk of bias
Incomplete outcome data  low risk of bias
Selective reporting  unclear risk of bias
Other bias  low risk of bias
Unclear risk
Wanyenze [39] Individual randomized controlled trial Radom sequence generation  low risk of bias
Allocation concealment  low risk of bias
Blinding of participants  not feasible
Blinding of outcome assessment  unclear risk of bias
Incomplete outcome data  unclear risk of bias
Selective reporting  low risk of bias
Other bias  unclear risk of bias
Low risk
Hatcher [25] Observational study with control group 0-0-0 1-0 0-1-0 High risk
Pfeiffer [48] Observational study with control group 1-0-0 0-0 0-1-0 Unclear risk
Tsague [40] Observational study with control group 1-1-1 0-0 0-1-0 Unclear risk
Larson [23] Observational study with control group 1-1-1 1-0 0-1-0 Unclear risk
Stinson [45] Observational study with control group 1-1-1 1-0 0-1-0 Unclear risk
Topp [53] Observational study with control group 1-1-1 1-1 0-1-0 Low risk
Choun [37] Before/after study 1-1-1 1-0 0-1-1 Low risk
Kundu [35] Before/after study 1-0-1 0-0 0-1-1 High risk
Kohler [50] Before/after study 1-1-1 1-0 0-1-1 Low risk
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to or retention in pre-ART care and initiation of ART.
The majority of these studies were conducted in sub-Saharan
Africa and most were observational in design. Patient centred
strategies to minimize clinic visits, integration of ART care
into antenatal services, education and support for those
enrolled in pre-ART care, and incentivized clinic attendance
all showed promising results. However, there is a paucity of
studies focusing on specific key populations and few studies
have investigated a combination of interventions and the
impact of these interventions at multiple steps along the pre-
ART period. This review suggests that whilst some interven-
tions are specific to certain points along the cascade (e.g.
POC CD4 testing for the improvement of linkage to pre-ART
care), there are interventions that could potentially support
linkage and retention along the entire HIV cascade both in
pre-ART and ART care (e.g. integration of HIV services, food
incentives, patient navigators) and thus warrants further
investigation.
Attending pre-ART clinic visits is a major challenge among
patients in low- and middle-income countries due to high
transport costs, distance to health care facilities, inability to
take time off work, and long clinic waiting times [10] as well
as the lack of services (perceived or actual) provided during
the pre-ART period [9,10]. Interventions such as POC CD4
testing, home-based ART initiation and integrated service
delivery, aimed at decreasing the number of pre-ART visits
prior to ART initiation, have proven successful, particularly
for those patients immediately eligible for ART. The use of
POC CD4 technology or immediate CD4 count testing in
South Africa and Mozambique have shown higher comple-
tion of ART eligibility assessment, shorter time to staging
and ART initiation, and an increase in ART initiations [21
23,38]. Home-based ART initiation is a viable strategy to
effectively improve population-level ART initiation as indicated
in a trial offering HIV self-testing from Malawi [26]. ‘‘Fast
tracking’’ of patients through the provision of counselling
and ART eligibility assessment in TB and ANC settings facil-
itated prompt ART initiation with decreased numbers of
clinic visits [37,41]. Results from a randomized controlled
trial investigating same day ART initiation on the day of HIV
diagnosis, currently underway in South Africa, may provide
further evidence on the effect of rapid ART initiation on patient
outcomes [63]. However, the long-term effect of reducing
the number of clinic visits prior to ART initiation remains
unclear. There has been no study to date, except for the
Malawian study [26], that has followed-up patients beyond
the pre-ARTperiod, and it is plausible that the improvement in
linkage and ART initiation is offset by increased default rates
once on ART. Given the high HIV burden in this resource-
constrained setting, there is a clear need for prioritizing pa-
tients based on their baseline CD4 count and urgency to link
to care, with more support (e.g. patient navigation, fast-
tracking, home-based ART initiation) provided to patients with
lower CD4 counts compared to those with higher CD4 counts.
Apart from reducing clinic visit frequency, inflexible clinic
hours have been identified as another barrier to accessing
care, especially among the working population [10,69,70].
However, none of the included studies investigated the
effect of providing services outside traditional clinic operatingTa
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hours (e.g. evenings and weekends). In addition, interven-
tions targeted at reducing waiting times through increased
medical and administrative staffing levels, or appointment-
based systems, are yet to be evaluated. A qualitative study
from Tanzania investigating referral systems between testing
and treatment found that the provision of a transport allow-
ance was a key facilitator to linkage to ARTcare [24]; however,
no study has investigated the impact of transport provision,
subsidies, or vouchers on linkage to pre-ART or ART care.
Several studies have investigated the effect of bringing
HIV care services closer to where patients reside through
decentralization and service integration to overcome issues
of distance and difficulties to pay for transport in the context
of pre-ART care. A recent systematic review assessing the
influence of various models of decentralized HIV treatment
and care on initiating and maintaining ART concluded that
partial decentralization can decrease attrition of patients on
ART [71]. Currently, there is recommendation from recent
WHO guidelines to decentralize HIV services from secondary
care (e.g. district hospitals) to primary health care clinics [14].
This often goes along with task shifting ART initiation and
patient management from doctors to nurses. This is supported
by a cluster randomized trial of nurse-led ART initiation in
South Africa which showed no detrimental impact on reten-
tion in pre-ART care, or immunological and virological out-
comes at six months, suggesting that task shifting is a viable
approach in some settings [51]. The provision of ART initiation
services within or near to ANC clinics as part of a ‘‘package’’
of PMTCT interventions was shown in two studies to increase
the proportion of eligible women on ARTat delivery [41,44]. In
contrast, a positive correlation was seen between distance
from the clinic and enrolment for HIV care in an ANC study,
suggesting that more distant services were preferred, perhaps
due to issues of confidentiality and stigma [25]. These dif-
ferences are likely to be context specific and therefore this
area merits further investigation in different context. Of
note, integration of services (i.e. ANC, post-natal and HIV)
without clear delineation of the roles, responsibilities and
authorities between services could disrupt the continuum of
care for women on ART during pregnancy and thus pro-
gramme planners should consider these requirements prior
to implementation.
This review identifies that peer support and appropriate
counselling may facilitate linkage to care. Stigma has been
identified as a barrier to care at all steps of the HIV cascade,
including HIV testing [72], linkage to care [10,73], and ART
adherence [74,75]. Fear of disclosure of one’s HIV-positive
status is also a reported barrier to care [10], but if achieved,
disclosure can support linkage to care [10,76]. Appropriate
counselling has been shown to promote disclosure of HIV
status to family members, improve adherence to treatment,
and promote psychological wellbeing [7783]. A randomized
control trial conducted in Uganda showed that combined
post-test counselling by trained staff with home visits by
community support agents for on-going counselling also
improved linkage to ART services [52]. The costs and feasi-
bility of this labour-intensive approach on a large scale need
assessment and further investigation of the effect of different
models of post-test counselling on linkage to care is therefore
warranted. The use of community-based peer support pro-
vided by health care workers and expert patients has been
associated with higher rates of ART initiation in the general
adult population and ANC settings [43,44]. Several on-going
studies will provide evidence into the effect of support
systems on ART initiation in high-risk groups such as injecting
drug users [54,66,68], pregnant women, and their partners
[56]. Mobile phone technologies have been used to trace and
support patients once on ART [19,78], and two on-going
trials will provide clarity around the effectiveness of the use of
mobile technology in pre-ART retention [57,60].
There have been few studies on the use of incentives
to improve retention in pre-ART care, including nutritional
support, free medications, and conditional cash transfers.
Food insecurity was highlighted as a barrier to pre-ART care
in a recent systemic review [10] and studies assessing the use
of food incentives have shown improved linkage to care in
children and injecting drug users [35,36]. Given the potential
of improved nutrition to improve treatment outcomes for
HIV-positive patients, this area deserves further attention,
although costs and feasibility need careful assessment.
The provision of free co-trimoxazole was shown to increase
retention in pre-ART care for ART-ineligible patients from 63
to 84% in a Kenyan study [50], and further investigation into
the cost-effectiveness of medical incentives on retention in
pre-ART care are required. Conditional cash transfers have
previously been used to promote HIV testing [8486], and to
encourage patients to maintain their HIV-negative status
[87,88], but their effect on retention in pre-ART care has not
yet been assessed.
This review showed a lack of studies testing interven-
tions aimed at key populations. Men have less access to and
coverage of HIV testing and ART in most settings and are
at higher risk of attrition from ART and pre-ART services.
No study investigating interventions specifically targeted at
men were identified [10,8997]. In addition, despite the high
rates of pre-ART attrition amongst children [12] and poor
treatment outcomes in adolescents [98100], only one study
was focused on each of these respective groups [35,38].
Ways to support linkage to care for other vulnerable groups
such as migrants, prisoners and those in closed settings, sex
workers, men who have sex with men, people who inject
drugs, and those with HIV-TB co-infection should also be
assessed.
Overall, most studies investigated the impact of individual
interventions on one stage of the cascade, mainly stages
2 and 3 and few studies have investigated interventions for
stage 1, linkage to HIV care.
A single intervention is unlikely to solve attrition across
all steps in the pre-ART period and to address the different
reasons for attrition. Although, certain interventions such a
POC CD4 counting are effective in improving time to linkage
to HIV care and completion of ART eligibility screening, it may
be a less suitable intervention for improving pre-ART reten-
tion, in contrast to food and medical incentives. The effect
of interventions targeted at a single point in the pathway
might be limited when assessed across the entire pre-ART
period. Loss to follow-up prevented earlier on in the pathway
might not guarantee retention later on. However, most of
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the planned or on-going trials investigate single interven-
tions with limited follow-up time. Therefore, a combination of
interventions to address the main points at which patient
drop-out of care during the pre-ARTperiod or while on ARTare
most likely to be successful. This package should include
interventions aimed at increasing patient convenience and
accessibility (e.g. POC CD4 count testing, inpatient testing,
home visits and possibly home-based ART initiation) as this
was found to be effective in increasing ART eligibility screen-
ing and initiation rates; health system interventions such as
integration of ART and ANC care as this appears to increase
HIV care and ART enrolment; behavioural interventions and
peer support (e.g. intensified post-test counselling and peer
support) as these were found to increase linkage to care.
HIV programmes should first determine the patient groups
at risk for drop-out in their cohorts and reasons for drop-
out (e.g. too ill to travel to the clinic, disclosure and stigma
issues) in order to inform the selection of an effective package
of interventions. Programme planners should be mindful of
several key factors when selecting interventions i.e.: the
operational needs of specific interventions (e.g. staff duties,
supplies, data collection systems), challenges in implement-
ing and maintaining interventions (i.e. POC CD4 count test-
ing, integration of care), interventions studied (e.g. incentives)
could be context-specific and may be need to be tailored to
the target population in their settings. Furthermore, pro-
grammes adopting the WHO guidelines supporting earlier
ART initiation will likely observe a significant reduction in
the number of people with HIV required to remain in the
‘‘pre-ART’’ period, however these programmes will need to
implement interventions to improve immediate linkage to
ART care as majority of people will require ART care.
The main strengths of this review are the use of a broad
search strategy that included an extensive expert consulta-
tion, allowing identification of both published and unpub-
lished studies as well as information on on-going trials, a
rigorous assessment of study risk of bias and quality. This
assessment found that the evidence base and methodology
of this current review was subject to several limitations.
Firstly, the quality of studies was limited with the majority
of studies being observational, using time series rather than
concurrent control groups, and subject to unclear risk of bias.
Outcome ascertainment was rarely adequately described
and time delineation was often lacking, making it difficult
to compare outcomes and calculate summary estimates.
Assessment of cost-effectiveness and patient acceptability
were absent from all studies. Publication bias is likely present
as studies with unfavourable results are less likely to be
published. In addition, HIV programme evaluation reports
from resource-limited settings might not necessarily be
published and thus might have been missed by this review.
While the literature review was extensively conducted in four
international databases including primarily studies published
in peer reviewed journals, regional databases such as the
African Healthline and LILAC were not searched. The review
was limited to low- and middle-income countries. Thus some
potential interventions from high income countries which
might be applicable to low- and middle-income countries
were not included in the review. Most of the studies included
were conducted in sub-Saharan Africa, limiting the general-
izability of our findings beyond this region and even within
the region there is considerable heterogeneity of current
service delivery models and approaches. Most studies
assessed interventions within the ANC and PMTCT setting
and thus findings may not be generalizable to general HIV
care programmes. Finally, the majority of studies looked at
the effect of a single intervention on a single point in the
HIV continuum.
Conclusions
The overall findings from this review suggest that streamlin-
ing services to minimize patient facility visits, providing
adequate counselling, medical and peer support, and provid-
ing incentives may decrease attrition between HIV testing
and ART initiation. Further implementation research, focused
programme evaluation and studies with rigorous study
designs investigating the impact of individual interventions
and a combination of interventions across the HIV cascade,
including for the various groups at high risk of attrition, is
warranted in order to inform HIV policy and programmes.
There is a specific need to also evaluate interventions for key
populations as currently they are not only disproportionately
affected by HIV but have lower access to and coverage of HIV
testing and ART.
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